SELLAS Life Sciences Group, Inc. (SLS)

NASDAQ: SLS · Real-Time Price · USD

14.98

+1.71 (12.89%)

At close: Jul 2, 2026, 4:00 PM EDT

14.99

+0.01 (0.07%)

After-hours: Jul 2, 2026, 5:21 PM EDT

SLS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,787	577	77	34	49	88
Market Cap Growth	1635.22%	650.23%	125.88%	-29.90%	-44.69%	6.07%
Enterprise Value	2,510	506.31	63.95	32.34	32.31	67.2
Last Close Price	14.98	3.77	1.04	1.06	2.36	5.53
PS Ratio	-	-	-	-	48.59	11.56
PB Ratio	22.40	8.14	8.13	-4.27	10.02	4.32
P/TBV Ratio	18.48	5.96	8.43	-	15.59	4.64
EV/Sales Ratio	-	-	-	-	32.31	8.84
Debt / Equity Ratio	0.00	0.01	0.05	-0.06	0.12	0.03
Net Debt / Equity Ratio	-0.99	-1.00	-1.37	0.22	-3.36	-1.01
Net Debt / EBITDA Ratio	3.38	2.51	0.41	0.05	0.39	0.82
Net Debt / FCF Ratio	3.78	2.50	0.37	0.06	0.68	0.79
Asset Turnover	-	0	0	0	0.04	0.21
Quick Ratio	16.60	10.25	1.47	0.19	1.11	4.31
Current Ratio	17.22	10.72	1.72	0.23	1.14	4.63
Return on Equity (ROE)	-33.05%	-66.88%	-4147.88%	2389.76%	-327.81%	-85.70%
Return on Assets (ROA)	-32.69%	-57.83%	-245.71%	-278.84%	-177.69%	-69.15%
Return on Invested Capital (ROIC)	-868.18%	-771.78%	-882.47%	-603.39%	-671.85%	-273.02%
Return on Capital Employed (ROCE)	-35.14%	-69.60%	-2619.53%	3627.30%	-313.99%	-91.97%
Buyback Yield / Dilution	-81.03%	-78.18%	-120.33%	-43.21%	-25.29%	-94.07%
Total Shareholder Return	-81.03%	-78.18%	-120.33%	-43.21%	-25.29%	-94.07%

SEC Filings: 10-K · 10-Q